Lecithin
- Generic Name
- Lecithin
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- -
- CAS Number
- 8002-43-5
- Unique Ingredient Identifier
- -
- Background
A complex mixture of phospholipids, glycolipids, triglycerides, phosphatidylcholines, phosphatidylethanolamines, and phosphatidylinositols.
- Indication
用于脂肪肝、动脉粥样硬化等疾病的辅助治疗。
- Associated Conditions
- -
- Associated Therapies
- -
Essentiale® Paste in Patients With Gastrointestinal Symptoms in Acute or Chronic Liver Diseases
- First Posted Date
- 2015-08-07
- Last Posted Date
- 2016-07-04
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 147
- Registration Number
- NCT02517385
Phosphatidylcholine Supplementation in Infants
Phase 1
Withdrawn
- Conditions
- SchizophreniaDiminished P50 Sensory Gating
- Interventions
- Drug: phosphatidylcholine supplementationDrug: placebo
- First Posted Date
- 2013-07-23
- Last Posted Date
- 2020-09-02
- Lead Sponsor
- University of Colorado, Denver
- Registration Number
- NCT01905605
- Locations
- 🇺🇸
University of Colorado Denver, Aurora, Colorado, United States
Study of Phosphatidylcholine in a Patient With Methionine Adenosyltransferase Deficiency
Not Applicable
Completed
- Conditions
- Methionine Adenosyltransferase DeficiencyMetabolism, Inborn Errors
- First Posted Date
- 2000-07-06
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- National Center for Research Resources (NCRR)
- Target Recruit Count
- 1
- Registration Number
- NCT00006061
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath